Brief: Achieve Life Sciences Receives FDA Commissioner's National Priority Voucher For Cytisinicline For Treatment Of Nicotine Dependence For E-Cigarette Or Vaping Cessation

Achieve Life Sciences

17/10/2025 12:33

Oct 17 (Reuters) - Achieve Life Sciences Inc ACHV.O:

ACHIEVE LIFE SCIENCES RECEIVES FDA COMMISSIONER'S NATIONAL PRIORITY VOUCHER FOR CYTISINICLINE FOR TREATMENT OF NICOTINE DEPENDENCE FOR E-CIGARETTE OR VAPING CESSATION

ACHIEVE LIFE SCIENCES INC - FDA-ASSESSMENT TIME REDUCED TO 1-2 MONTHS FOR CYTISINICLINE

Source text: ID:nGNX4nHRGh

Further company coverage: ACHV.O